Switching from statin monotherapy to ezetimibe/simvastatin or rosuvastatin modifies the relationships between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients at high risk of coronary disease
Helena Vaverkova, Michel Farnier, Maurizio Averna, Luc Missault, Margus Viigimaa, Qian Dong, Arvind Shah, Amy O. Johnson-Levonas, Philippe BrudiТом:
44
Рік:
2011
Мова:
english
Сторінки:
8
DOI:
10.1016/j.clinbiochem.2011.02.008
Файл:
PDF, 535 KB
english, 2011